Plaque psoriasis
Adult: Moderate to severe cases in patients who are candidates for systemic therapy or phototherapy: Initially, 100 mg at weeks 0 and 4, followed by a maintenance dose of 100 mg every 8 weeks. Consider treatment discontinuation if there is no response after 16 weeks.
Subcutaneous
Psoriatic arthritis
Adult: As monotherapy or in combination with methotrexate in patients who had an inadequate response or are intolerant to a previous disease-modifying antirheumatic drugs (DMARDs) therapy: Initially, 100 mg at weeks 0 and 4, followed by a maintenance dose of 100 mg every 8 weeks. In patients who are at high risk for joint damage: 100 mg every 4 weeks may be considered. Consider treatment discontinuation if there is no response after 24 weeks.